SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001693011-18-000003
Filing Date
2018-11-21
Accepted
2018-11-21 16:20:01
Documents
1
Effectiveness Date
2018-11-21
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 8903
  Complete submission text file 0001693011-18-000003.txt   10055
Mailing Address 280 SUMMER STREET 5TH FLOOR BOSTON MA 02210
Business Address 280 SUMMER STREET 5TH FLOOR BOSTON MA 02210 857-330-4340
Inozyme Pharma, Inc. (Filer) CIK: 0001693011 (see all company filings)

IRS No.: 475129768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-277738 | Film No.: 181198410